TN2013000426A1 - Triazolopyridines - Google Patents
TriazolopyridinesInfo
- Publication number
- TN2013000426A1 TN2013000426A1 TNP2013000426A TN2013000426A TN2013000426A1 TN 2013000426 A1 TN2013000426 A1 TN 2013000426A1 TN P2013000426 A TNP2013000426 A TN P2013000426A TN 2013000426 A TN2013000426 A TN 2013000426A TN 2013000426 A1 TN2013000426 A1 TN 2013000426A1
- Authority
- TN
- Tunisia
- Prior art keywords
- compounds
- triazolopyridines
- prophylaxis
- disease
- preparing
- Prior art date
Links
- 150000008523 triazolopyridines Chemical class 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 5
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
The present invention relates to triazolopyridine compounds of general formula (I) : in which R1, R2, R3, R4, and R5 are as given in the description and in the claims, to methods of preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds, to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, as well as to intermediate compounds useful in the preparation of said compounds.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11167872 | 2011-05-27 | ||
| PCT/EP2012/056914 WO2012143329A1 (en) | 2011-04-21 | 2012-04-16 | Triazolopyridines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TN2013000426A1 true TN2013000426A1 (en) | 2015-03-30 |
Family
ID=52394781
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNP2013000426A TN2013000426A1 (en) | 2011-05-27 | 2013-10-18 | Triazolopyridines |
Country Status (2)
| Country | Link |
|---|---|
| CU (1) | CU24174B1 (en) |
| TN (1) | TN2013000426A1 (en) |
-
2012
- 2012-04-16 CU CUP2013000141A patent/CU24174B1/en active IP Right Grant
-
2013
- 2013-10-18 TN TNP2013000426A patent/TN2013000426A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CU20130141A7 (en) | 2014-03-26 |
| CU24174B1 (en) | 2016-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JO3040B1 (en) | Triazolopyridines | |
| JO3111B1 (en) | Substituted triazolopyridines and their use as ttk inhibitors | |
| TN2012000595A1 (en) | Substituted triazolopyridines | |
| TN2012000265A1 (en) | Triazolopyridines | |
| PH12013500454A1 (en) | Substituted imidazopyridazines | |
| TW201613874A (en) | Benzimidazol-2-amines as mIMH1 inhibitors | |
| PH12014500501A1 (en) | Amino-substituted imidazopyridazines | |
| IN2012DN02139A (en) | ||
| MX2019012939A (en) | Linaclotide-containing formulations for oral administration. | |
| MX2014010433A (en) | Novel crystalline form of sitagliptin sulfate. | |
| PH12016500054A1 (en) | Substituted pyrazolo-pyridinamines | |
| PH12015502747A1 (en) | Novel compounds for the treatment of cancer | |
| PH12015500061A1 (en) | Method for preparing substituted triazolopyridines | |
| PH12015502703A1 (en) | Pharmaceutical compositions | |
| TN2013000426A1 (en) | Triazolopyridines | |
| SA112330437B1 (en) | Pharmaceutical compositions containing hypnotic or anesthetic agent and method for their preparation |